Charles R Sanders Iii
Manager, Pharmacy at Greenville Health Corporation · SC · Healthcare
$252K
Peak Total Compensation
6
Years Tracked
3x
vs. Median Household
Charles R Sanders Iii has appeared in compensation disclosures over 6 years of available data (2019–2024). Total compensation changed from $168,138 to $251,619 - a 49.7% increase.
Peak total compensation of $251,619 equals 3x the median U.S. household income ($75,000).
Compensation History
Year-by-Year Detail
| Year | Organization | Title | Compensation | Other | Total |
|---|---|---|---|---|---|
| 2024 | Greenville Health Corporation | Manager, Pharmacy | $214,786 | $36,833 | $251,619 |
| 2023 | Greenville Health Corporation | Manager, Pharmacy | $169,271 | $18,912 | $188,183 |
| 2022 | Greenville Health Corporation | Manager, Pharmacy | $185,774 | $19,669 | $205,443 |
| 2021 | GREENVILLE HEALTH CORPORATION | MANAGER, PHARMACY | $166,757 | $31,749 | $198,506 |
| 2020 | GREENVILLE HEALTH CORPORATION | MANAGER, PHARMACY | $159,536 | $38,014 | $197,550 |
| 2019 | GREENVILLE HEALTH CORPORATION | MANAGER, PHARMACY-AMBULATORY | $131,263 | $36,875 | $168,138 |
Peers at Greenville Health Corporation
| Name | Title | Peak Comp. |
|---|---|---|
| Mark S O'Halla | President and CEO of Prisma Health | $2.9M |
| Greg Rusnak | COO - UAO | $2.6M |
| Clarence M Sevillian Ii | EVP Chief Operating Officer | $2.1M |
| Howard P West | Frmr EVP Chief Legal Officer (until 9/30/23) | $2.0M |
| Michael C Riordan | FORMER CO-CEO OF PH (TO 6/19) | $1.9M |
| Matthew M Elsey | President | $1.8M |
| Jonathan L Gleason Md | EVP Chief Clinical Officer | $1.8M |
| Charles D Beaman Jr | FORMER CO-CEO OF PRISMA HEALTH (UNTIL 7/19) | $1.6M |
| Jean M Meyer | Frmr SVP-Acute Care Svcs & Chief Nursing Exec (until 9/30/23) | $1.6M |
| Richard J Rogers | SVP Chief Information Officer | $1.5M |
Email Alerts
Get notified about Charles R Sanders Iii
Get an email when a new IRS Form 990 filing is posted that includes this executive. We send a confirmation link first - we don't add you to any other list.
Compare with another executive: Open comparison tool →